References: Community-acquired pneumonia in adults

  • Acar S, Keskin-Arslan E, Erol-Coskun H, Kaya-Temiz T, Kaplan YC. Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: A systematic review and meta-analysis. Reprod Toxicol 2019;85:65-74. https://www.ncbi.nlm.nih.gov/pubmed/30738954
  • Al-Salloum J, Gillani SW, Mahmood RK, Gulam SM. Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review. J Int Med Res 2021;49(10):3000605211049943. https://www.ncbi.nlm.nih.gov/pubmed/34719987
  • Aldhahri RK, Gabb SG, Shoaib OA, Almadani RM, Eljaaly K, Thabit AK. Doxycycline vs. macrolides in combination with a beta-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients. Eur J Med Res 2022;27(1):279. https://www.ncbi.nlm.nih.gov/pubmed/36482485
  • Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI. Community-acquired pneumonia. Lancet 2021;398(10303):906-19. https://www.ncbi.nlm.nih.gov/pubmed/34481570
  • Allgaier J, Lagu T, Haessler S, Imrey PB, Deshpande A, Guo N, et al. Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample. Chest 2021;159(5):1782-92. https://www.ncbi.nlm.nih.gov/pubmed/33352192
  • Athlin S, Magnuson A, Spindler C, Hedlund J, Stralin K, Naucler P. Pneumococcal urinary antigen testing for antimicrobial guidance in community-acquired pneumonia-A register-based cohort study. J Infect 2022;85(2):167-73. https://www.ncbi.nlm.nih.gov/pubmed/35618153
  • Australasian College for Emergency Medicine (ACEM) and the Royal College of Pathologists of Australasia (RCPA). Pathology testing in the emergency department. Melbourne: ACEM & RCPA; 2013, revised 2018. https://www.rcpa.edu.au/Library/College-Policies
  • Australian Commission on Safety and Quality in Health Care (ACSQHC). AURA 2023: Fifth Australian report on antimicrobial use and resistance in human health. Sydney: Australian Commission on Safety and Quality in Health Care (ACSQHC),; 2023. Updated 16 Nov 2023. Accessed 16 Nov 2023. https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-aura/aura-2023-fifth-australian-report-antimicrobial-use-and-resistance-human-health
  • Bellew S, Grijalva CG, Williams DJ, Anderson EJ, Wunderink RG, Zhu Y, et al. Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing. Clin Infect Dis 2019;68(12):2026-33. https://www.ncbi.nlm.nih.gov/pubmed/30265290
  • Bergmann F, Pracher L, Sawodny R, Blaschke A, Gelbenegger G, Radtke C, et al. Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials. Clin Infect Dis 2023;77(12):1704-13. https://www.ncbi.nlm.nih.gov/pubmed/37876267
  • Briggs GG, Towers CV, Forinash AB, Ovid Technologies Inc. Briggs drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk. 12th ed. Philadelphia, PA: Wolters Kluwer,; 2022. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=booktext&NEWS=N&DF=bookdb&CSC=Y&AN=02238389/12th_Edition&XPATH=/PG(0)
  • Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008;46(10):1513-21. https://www.ncbi.nlm.nih.gov/pubmed/18419484
  • Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, et al. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med 2024;52(5):e219-e33. https://www.ncbi.nlm.nih.gov/pubmed/38240492
  • Chidiac C, SPILF working group. Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin. SPILF.). Med Mal Infect 2015;45(9):348-73. https://www.ncbi.nlm.nih.gov/pubmed/26432627
  • Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M. Efficacy of Doxycycline for Mild-to-moderate Community-acquired Pneumonia in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Infect Dis 2022. https://www.ncbi.nlm.nih.gov/pubmed/35903011
  • Chow EJ, Beigi RH, Riley LE, Uyeki TM. Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy. Open Forum Infect Dis 2021;8(6):ofab138. https://www.ncbi.nlm.nih.gov/pubmed/34189160
  • Cilloniz C, Dominedo C, Gabarrus A, Garcia-Vidal C, Becerril J, Tovar D, et al. Methicillin-susceptible staphylococcus aureus in community-acquired pneumonia: Risk factors and outcomes. J Infect 2021;82(1):76-83. https://www.ncbi.nlm.nih.gov/pubmed/33144192
  • Claessens YE, Berthier F, Baque-Juston M, Perrin C, Faraggi M, Keita-Perse O, et al. Early chest CT-scan in emergency patients affected by community-acquired pneumonia is associated with improved diagnosis consistency. Eur J Emerg Med 2022;29(6):417-20. https://www.ncbi.nlm.nih.gov/pubmed/35762442
  • Claessens YE, Debray MP, Tubach F, Brun AL, Rammaert B, Hausfater P, et al. Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia. Am J Respir Crit Care Med 2015;192(8):974-82. https://www.ncbi.nlm.nih.gov/pubmed/26168322
  • Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf 2016;15(3):367-82. https://pubmed.ncbi.nlm.nih.gov/26680308/
  • Dang TT, Majumdar SR, Marrie TJ, Eurich DT. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients. Drugs Aging 2015;32(1):13-9. https://pubmed.ncbi.nlm.nih.gov/25491559/
  • Davis JS, McMillan M, Swaminathan A, Kelly JA, Piera KE, Baird RW, et al. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols. Chest 2014;146(4):1038-45. https://pubmed.ncbi.nlm.nih.gov/24901292/
  • Del Rio-Pertuz G, Gutierrez JF, Triana AJ, Molinares JL, Robledo-Solano AB, Meza JL, et al. Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia: a systematic review and meta-analysis. BMC Infect Dis 2019;19(1):403. https://www.ncbi.nlm.nih.gov/pubmed/31077143
  • Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med 2023;388(21):1931-41. https://www.ncbi.nlm.nih.gov/pubmed/36942789
  • Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, et al. Discontinuing beta-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 2021;397(10280):1195-203. https://www.ncbi.nlm.nih.gov/pubmed/33773631
  • Ehsanpoor B, Vahidi E, Seyedhosseini J, Jahanshir A. Validity of SMART-COP score in prognosis and severity of community acquired pneumonia in the emergency department. Am J Emerg Med 2019;37(8):1450-4. https://www.ncbi.nlm.nih.gov/pubmed/30401592
  • Falcone M, Russo A, Tiseo G, Cesaretti M, Guarracino F, Menichetti F. Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy. Infection 2021;49(2):321-5. https://www.ncbi.nlm.nih.gov/pubmed/33315182
  • Fan H, Gilbert R, O'Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. BMJ 2020;368:m331. https://www.ncbi.nlm.nih.gov/pubmed/32075790
  • Fan H, Li L, Wijlaars L, Gilbert RE. Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: A systematic review and meta-analysis. PLoS One 2019;14(2):e0212212. https://www.ncbi.nlm.nih.gov/pubmed/30779772
  • File TM, Jr., Ramirez JA. Community-Acquired Pneumonia. N Engl J Med 2023;389(7):632-41. https://www.ncbi.nlm.nih.gov/pubmed/37585629
  • Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336(4):243-50. https://pubmed.ncbi.nlm.nih.gov/8995086/
  • Frenzen FS, Kutschan U, Meiswinkel N, Schulte-Hubbert B, Ewig S, Kolditz M. Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Clin Microbiol Infect 2018;24(3):306.e1-.e6. https://pubmed.ncbi.nlm.nih.gov/28710027/
  • Garin N, Marti C, Skali Lami A, Prendki V. Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review. Microorganisms 2022;10(12). https://www.ncbi.nlm.nih.gov/pubmed/36557579
  • Greenfield A, Marsh K, Siegfried J, Zacharioudakis I, Ahmed N, Decano A, et al. Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients With Community-Acquired Pneumonia Admitted Within a Large Academic Health System. Open Forum Infect Dis 2022;9(1):ofab522. https://www.ncbi.nlm.nih.gov/pubmed/34993258
  • Hill AT, Gold PM, El Solh AA, Metlay JP, Ireland B, Irwin RS, et al. Adult Outpatients With Acute Cough Due to Suspected Pneumonia or Influenza: CHEST Guideline and Expert Panel Report. Chest 2019;155(1):155-67. https://www.ncbi.nlm.nih.gov/pubmed/30296418
  • Hill K, Sucha E, Rhodes E, Carrier M, Garg AX, Harel Z, et al. Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants. JAMA Intern Med 2020;180(8):1052-60. https://www.ncbi.nlm.nih.gov/pubmed/32511684
  • Hincapie C, Ascuntar J, Leon A, Jaimes F. Community-acquired pneumonia: comparison of three mortality prediction scores in the emergency department. Colomb Med (Cali) 2021;52(4):e2044287. https://www.ncbi.nlm.nih.gov/pubmed/35499040
  • Hyams C, Williams OM, Williams P. Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice? ERJ Open Res 2020;6(1). https://www.ncbi.nlm.nih.gov/pubmed/31956656
  • Ito A, Ishida T, Tachibana H, Nakanishi Y, Yamazaki A, Washio Y. Predictors and usefulness of targeted therapy for pneumococcal community-acquired pneumonia diagnosed by the urinary antigen test: a prospective, observational cohort study. Diagn Microbiol Infect Dis 2021;101(1):115457. https://www.ncbi.nlm.nih.gov/pubmed/34271234
  • Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015;373(5):415-27. https://pubmed.ncbi.nlm.nih.gov/26172429/
  • Jasper AS, Musuuza JS, Tischendorf JS, Stevens VW, Gamage SD, Osman F, et al. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis. Clin Infect Dis 2021;72(11):1979-89. https://www.ncbi.nlm.nih.gov/pubmed/32296816
  • Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63(5):e61-e111. https://pubmed.ncbi.nlm.nih.gov/27418577/
  • Kato H, Hagihara M, Asai N, Hirai J, Yamagishi Y, Iwamoto T, et al. Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2022;11(10). https://www.ncbi.nlm.nih.gov/pubmed/36289949
  • Kawasaki T, Nakagawa N, Murata M, Yasuo S, Yoshida T, Ando K, et al. Diagnostic accuracy of urinary antigen tests for legionellosis: A systematic review and meta-analysis. Respir Investig 2022;60(2):205-14. https://www.ncbi.nlm.nih.gov/pubmed/34972680
  • Kolditz M, Braeken D, Ewig S, Rohde G. Severity assessment and the immediate and long-term prognosis in community-acquired pneumonia. Semin Respir Crit Care Med 2016;37(6):886-96. https://pubmed.ncbi.nlm.nih.gov/27960212/
  • Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One 2015;10(6):e0128004. https://pubmed.ncbi.nlm.nih.gov/26042842/
  • Lan SH, Lai CC, Chang SP, Lu LC, Hung SH, Lin WT. Five-day antibiotic treatment for community-acquired bacterial pneumonia: A systematic review and meta-analysis of randomized controlled trials. J Glob Antimicrob Resist 2020;23:94-9. https://www.ncbi.nlm.nih.gov/pubmed/32866643
  • Leung PB, Davis AM, Davis J. Corticosteroids for Sepsis, Acute Respiratory Distress Syndrome, or Community-Acquired Pneumonia. JAMA 2025;333(5):421-2. https://www.ncbi.nlm.nih.gov/pubmed/39774599
  • Llor C, Perez A, Carandell E, Garcia-Sangenis A, Rezola J, Llorente M, et al. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial. Aten Primaria 2019;51(1):32-9. https://www.ncbi.nlm.nih.gov/pubmed/29061311
  • Lopez-Alcalde J, Rodriguez-Barrientos R, Redondo-Sanchez J, Munoz-Gutierrez J, Molero Garcia JM, Rodriguez-Fernandez C, et al. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database Syst Rev 2018;9(9):CD009070. https://www.ncbi.nlm.nih.gov/pubmed/30188565
  • Marchello CS, Ebell MH, Dale AP, Harvill ET, Shen Y, Whalen CC. Signs and Symptoms That Rule out Community-Acquired Pneumonia in Outpatient Adults: A Systematic Review and Meta-Analysis. J Am Board Fam Med 2019;32(2):234-47. https://www.ncbi.nlm.nih.gov/pubmed/30850460
  • Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J 2023;61(4). https://www.ncbi.nlm.nih.gov/pubmed/37012080
  • Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200(7):e45-e67. https://www.ncbi.nlm.nih.gov/pubmed/31573350
  • Mihovec K, Temova Rakusa Z, Gaal EE, Roskar R. Evaluation of the stability of hydrocortisone sodium succinate in solutions for parenteral use by a validated HPLC-UV method. Acta Chim Slov 2022;0(0):7539. https://pubmed.ncbi.nlm.nih.gov/36196797/
  • Moore M, Stuart B, Little P, Smith S, Thompson MJ, Knox K, et al. Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study. Eur Respir J 2017;50(5). https://www.ncbi.nlm.nih.gov/pubmed/29167296
  • Muyldermans A, Descheemaeker P, Boel A, Desmet S, Van Gasse N, Reynders M, et al. What is the risk of missing legionellosis relying on urinary antigen testing solely? A retrospective Belgian multicenter study. Eur J Clin Microbiol Infect Dis 2020;39(4):729-34. https://www.ncbi.nlm.nih.gov/pubmed/31838606
  • National Institute for Health and Care Excellence (NICE). Pneumonia (community-acquired): antimicrobial prescribing. London: National Institute for Health and Care Excellence (NICE); 2019. Accessed 16 April 2024. https://www.nice.org.uk/guidance/NG138
  • Neill S, Dean N. Aspiration pneumonia and pneumonitis: a spectrum of infectious/noninfectious diseases affecting the lung. Curr Opin Infect Dis 2019;32(2):152-7. https://www.ncbi.nlm.nih.gov/pubmed/30676341
  • Patel H, Calip GS, DiDomenico RJ, Schumock GT, Suda KJ, Lee TA. Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin. JAMA Netw Open 2020;3(9):e2016864. https://www.ncbi.nlm.nih.gov/pubmed/32930780
  • Polgreen LA, Riedle BN, Cavanaugh JE, Girotra S, London B, Schroeder MC, et al. Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities. J Am Heart Assoc 2018;7(9). https://www.ncbi.nlm.nih.gov/pubmed/29680825
  • Ramirez JA, Musher DM, Evans SE, Dela Cruz C, Crothers KA, Hage CA, et al. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. Chest 2020;158(5):1896-911. https://www.ncbi.nlm.nih.gov/pubmed/32561442
  • Rattanasuwan T. Short-Course Azithromycin for Lower Respiratory Tract Infection in Adults: Is 3 Days Enough? Infectious diseases in clinical practice 2021;29(3):E140-5.
  • Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J 2018;52(2). https://www.ncbi.nlm.nih.gov/pubmed/29976651
  • Reyes LF, Bastidas AR, Quintero ET, Frias JS, Aguilar AF, Pedreros KD, et al. Performance of the CORB (Confusion, Oxygenation, Respiratory Rate, and Blood Pressure) Scale for the Prediction of Clinical Outcomes in Pneumonia. Can Respir J 2022;2022:4493777. https://www.ncbi.nlm.nih.gov/pubmed/35692950
  • Rodriguez-Contreras FJ, Calvo-Cebrian A, Diaz-Lazaro J, Cruz-Arnes M, Leon-Vazquez F, Del Carmen Lobon-Agundez M, et al. Lung Ultrasound Performed by Primary Care Physicians for Clinically Suspected Community-Acquired Pneumonia: A Multicenter Prospective Study. Ann Fam Med 2022;20(3):227-36. https://www.ncbi.nlm.nih.gov/pubmed/35606120
  • Royer S, DeMerle KM, Dickson RP, Prescott HC. Shorter Versus Longer Courses of Antibiotics for Infection in Hospitalized Patients: A Systematic Review and Meta-Analysis. J Hosp Med 2018;13(5):336-42. https://www.ncbi.nlm.nih.gov/pubmed/29370318
  • Saleem N, Kulkarni A, Snow TAC, Ambler G, Singer M, Arulkumaran N. Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials. Chest 2023;163(3):484-97. https://www.ncbi.nlm.nih.gov/pubmed/36087797
  • Sando E, Suzuki M, Ishida M, Yaegashi M, Aoshima M, Ariyoshi K, et al. Definitive and Indeterminate Pseudomonas aeruginosa Infection in Adults with Community-acquired Pneumonia: A Prospective Observational Study. Ann Am Thorac Soc 2021;18(9):1475-81. https://www.ncbi.nlm.nih.gov/pubmed/33565942
  • See XY, Wang TH, Chang YC, Lo J, Liu W, Choo CYW, et al. Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis. BMJ Open Respir Res 2024;11(1). https://pubmed.ncbi.nlm.nih.gov/38262670/
  • Shirata M, Ito I, Ishida T, Tachibana H, Tanabe N, Konishi S, et al. Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults. Sci Rep 2021;11(1):23878. https://www.ncbi.nlm.nih.gov/pubmed/34903833
  • Simpson AJ, Allen JL, Chatwin M, Crawford H, Elverson J, Ewan V, et al. BTS clinical statement on aspiration pneumonia. Thorax 2023;78(Suppl 1):s3-s21. https://www.ncbi.nlm.nih.gov/pubmed/36863772
  • Smith S, Hanson J, Currie BJ. Melioidosis: An Australian Perspective. Trop Med Infect Dis 2018;3(1). https://www.ncbi.nlm.nih.gov/pubmed/30274424
  • Tansarli GS, Mylonakis E. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother 2018;62(9). https://pubmed.ncbi.nlm.nih.gov/29987137/
  • Tolppanen AM, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, et al. Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and those without Alzheimer disease. Chest 2016;150(6):1233-41. https://www.ncbi.nlm.nih.gov/pubmed/27298071
  • Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J 2017;50(3). https://www.ncbi.nlm.nih.gov/pubmed/28890434
  • Tsai D, Chiong F, Secombe P, Hnin KM, Stewart P, Goud R, et al. Epidemiology and microbiology of severe community-acquired pneumonia in Central Australia: a retrospective study. Intern Med J 2022;52(6):1048-56. https://www.ncbi.nlm.nih.gov/pubmed/33342052
  • Uddin M, Mohammed T, Metersky M, Anzueto A, Alvarez CA, Mortensen EM. Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia. Clin Infect Dis 2022;75(1):118-24. https://www.ncbi.nlm.nih.gov/pubmed/34751745
  • Uranga A, Espana PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M, et al. Duration of antibiotic treatment in community-acquired pneumonia: A multicenter randomized clinical trial. JAMA Intern Med 2016;176(9):1257-65. https://www.ncbi.nlm.nih.gov/pubmed/27455166
  • US Food and Drug Administration (FDA). Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Developing Drugs for Treatment: Guidance for Industry. Silver Spring, MD: FDA; 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-developing-drugs
  • van den Berk IAH, Kanglie M, van Engelen TSR, Altenburg J, Annema JT, Beenen LFM, et al. Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial. Thorax 2022. https://www.ncbi.nlm.nih.gov/pubmed/35688623
  • van Vugt SF, Verheij TJ, de Jong PA, Butler CC, Hood K, Coenen S, et al. Diagnosing pneumonia in patients with acute cough: clinical judgment compared to chest radiography. Eur Respir J 2013;42(4):1076-82. https://pubmed.ncbi.nlm.nih.gov/23349450/
  • Vaughn VM, Flanders SA, Snyder A, Conlon A, Rogers MAM, Malani AN, et al. Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia: A Multihospital Cohort Study. Ann Intern Med 2019;171(3):153-63. https://www.ncbi.nlm.nih.gov/pubmed/31284301
  • Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med 2018;378(9):797-808. https://www.ncbi.nlm.nih.gov/pubmed/29347874
  • Waterer GW. The Diagnosis of Community-acquired Pneumonia. Do We Need to Take a Big Step Backward? Am J Respir Crit Care Med 2015;192(8):912-3. https://www.ncbi.nlm.nih.gov/pubmed/26469839
  • Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, et al. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Neth J Med 2018;76(1):4-13. https://www.ncbi.nlm.nih.gov/pubmed/29380739
  • World Health Organization (WHO). Guidelines for the clinical management of severe illness from influenza virus infections. Geneva: World Health Organization (WHO); 2022. https://www.who.int/publications/i/item/9789240040816
  • World Health Organization (WHO). The top 10 causes of death. Fact Sheets. World Health Organization; 2021. 2024 (22/08/24) https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death
  • Yefet E, Schwartz N, Chazan B, Salim R, Romano S, Nachum Z. The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis. BJOG 2018;125(9):1069-76. https://www.ncbi.nlm.nih.gov/pubmed/29319210
  • Zhang YQ, Zou SL, Zhao H, Zhang MM, Han CL. Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis. Am J Emerg Med 2018;36(10):1759-65. https://www.ncbi.nlm.nih.gov/pubmed/29499898
  • Ziv A, Masarwa R, Perlman A, Ziv D, Matok I. Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis. Pharm Res 2018;35(5):109. https://www.ncbi.nlm.nih.gov/pubmed/29582196